Correlation Between Bone Biologics and Lifeline Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Lifeline Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Lifeline Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and Lifeline Biotechnologies, you can compare the effects of market volatilities on Bone Biologics and Lifeline Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Lifeline Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Lifeline Biotechnologies.
Diversification Opportunities for Bone Biologics and Lifeline Biotechnologies
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bone and Lifeline is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Lifeline Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifeline Biotechnologies and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Lifeline Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifeline Biotechnologies has no effect on the direction of Bone Biologics i.e., Bone Biologics and Lifeline Biotechnologies go up and down completely randomly.
Pair Corralation between Bone Biologics and Lifeline Biotechnologies
Assuming the 90 days horizon Bone Biologics is expected to generate 3.13 times less return on investment than Lifeline Biotechnologies. But when comparing it to its historical volatility, Bone Biologics Corp is 2.07 times less risky than Lifeline Biotechnologies. It trades about 0.09 of its potential returns per unit of risk. Lifeline Biotechnologies is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 0.03 in Lifeline Biotechnologies on September 23, 2024 and sell it today you would lose (0.02) from holding Lifeline Biotechnologies or give up 66.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 76.46% |
Values | Daily Returns |
Bone Biologics Corp vs. Lifeline Biotechnologies
Performance |
Timeline |
Bone Biologics Corp |
Lifeline Biotechnologies |
Bone Biologics and Lifeline Biotechnologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bone Biologics and Lifeline Biotechnologies
The main advantage of trading using opposite Bone Biologics and Lifeline Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Lifeline Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will offset losses from the drop in Lifeline Biotechnologies' long position.Bone Biologics vs. Bone Biologics Corp | Bone Biologics vs. Biofrontera Warrants | Bone Biologics vs. Inspira Technologies Oxy |
Lifeline Biotechnologies vs. Armm Inc | Lifeline Biotechnologies vs. Cellink AB | Lifeline Biotechnologies vs. Bone Biologics Corp | Lifeline Biotechnologies vs. BICO Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |